about
The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population.ADDing a piece to the puzzle of cognition in schizophrenia.Standardized remission criteria in schizophrenia.Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders.SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects.Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back.The comprehension of idiomatic expressions in schizophrenic patients.Detecting syntactic and semantic anomalies in schizophrenia.Sexually divergent effect of COMT Val/met genotype on subcortical volumes in schizophrenia.Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: persistence after 5years.Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.Theory of Mind intervention for outpatients with schizophrenia.Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia.Self-awareness of cognitive functioning in schizophrenia: patients and their relatives.Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement.Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence.Management of physical health in patients with schizophrenia: international insights.COMT and 5-HT1A-receptor genotypes potentially affect executive functions improvement after cognitive remediation in schizophrenia.HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.Theory of mind and emotion processing training for patients with schizophrenia: preliminary findings.Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study.Genetic dissection of drug effects in clinical practice: CLOCK gene and clozapine-induced diurnal sleepiness.Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment.Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia.Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.Cognitive remediation and functional improvement in schizophrenia: Is it a matter of size?Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia.The communicative impairment as a core feature of schizophrenia: Frequency of pragmatic deficit, cognitive substrates, and relation with quality of life.Achieving recovery in patients with schizophrenia through psychosocial interventions: A retrospective study.Abnormal cortico-limbic connectivity during emotional processing correlates with symptom severity in schizophrenia.Psychopathological and neuropsychological correlates of source monitoring impairment in schizophrenia.Exploring predictors of work competence in schizophrenia: The role of theory of mind.Shared reduction of oscillatory natural frequencies in bipolar disorder, major depressive disorder and schizophrenia.Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour.Emotional reactivity in chronic schizophrenia: structural and functional brain correlates and the influence of adverse childhood experiences.Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.Sterol Regulatory Element Binding Transcription Factor-1 Gene Variation and Medication Load Influence White Matter Structure in Schizophrenia.Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study.
P50
Q33335174-359BE8DE-DC00-4050-9D8C-FEE8EE4E85C6Q33362225-2AE119B9-7EE6-4A76-9CEE-D660260C2CF7Q34486075-ACDCADC4-04F3-4F40-94FE-90CAEBC18C47Q35057412-DB11C218-A008-4428-B4AF-1E5828BAF5ABQ37495004-088A94D3-92D0-44C3-941D-9F71F1F55F30Q38262765-1E8B64D9-68E9-489D-8C0A-CCE70EE41687Q38377239-FBA2F5EB-AA5D-4C84-A885-26C18E967C24Q38401070-6C73B17A-2994-488A-A13B-8732A55E30BBQ38699183-9E95905A-4D74-4263-A999-99F4B7E9519AQ38763029-19D4DD52-E44B-4979-9FA2-0E2E8F5FE751Q39281477-421AF847-24C6-46DB-B402-00AA78424A20Q39473207-28097FC9-05DC-4D00-9ABA-988795EC466CQ39597592-7370390C-47B8-46FD-8376-C2557D5DAAD6Q39642598-EBBB39A9-2993-4D71-A2F5-B28AC831FE2FQ40848645-221B8AAF-8DAE-4B13-8917-57A11693CEBCQ41252012-5B7C6E83-6AFB-470A-B556-BD8507024EA7Q42974032-D711C7E4-F641-4C98-8126-B6F133B753F2Q43170052-59C693F1-572D-41F4-B436-ECA69388DF14Q43264185-626B9D0B-1D19-43E9-A42B-4027636F1FD5Q43536563-313EE12F-2741-4298-9675-1E84959EBF31Q44026650-FACFBDC0-2DE4-45C7-9636-9A0DAF442F10Q44547216-DA6215E7-CBB8-4725-8CA5-CC85A0D4A773Q45031939-7AEFA7AE-2A55-4EE3-AC2C-980356156608Q45052993-4EB01E13-43D5-4717-A963-C309D50D94BBQ45070805-084E0312-AF60-46C0-A345-C1C002CA6BBCQ46008497-D7FCD22A-CFB8-4559-AE8C-50DDFE29F0B0Q46460488-ECDA78CA-3E92-4C16-B6A4-7FAEC9E474E7Q47258614-B580E285-9F88-4862-AF92-811BD21145DDQ47580844-49216FF4-5AC2-4C8E-9A15-7A2A94BA5F2BQ47637590-9977526E-1AE9-4112-A87F-D4C6C7E8EA45Q47688150-F86133F4-32DB-40A9-8B90-BD9084182184Q47745165-2587A3B4-A9C7-44F9-885C-3D1EEE314B4CQ47811252-451865EC-C772-433F-9B40-910DC26F10A0Q47906755-9220B153-7F95-402B-8291-09F59D920248Q47965080-2D1F3FAC-8DEC-434C-BF11-811F4004C36CQ47989035-260558CB-C03A-45F6-91EE-D81927B0E159Q48174288-BFEAF28D-2493-4CA7-A71E-8E29D7A7E7A0Q48229216-BE25F4FA-6B58-4A2B-9D35-834BA92907ECQ48230787-4C141D83-208F-47CA-832A-83FFD726C1D0Q48494982-FE2272FF-5F83-4EBF-A912-30F7A534B76A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberto Cavallaro
@ast
Roberto Cavallaro
@en
Roberto Cavallaro
@es
Roberto Cavallaro
@nl
Roberto Cavallaro
@sl
type
label
Roberto Cavallaro
@ast
Roberto Cavallaro
@en
Roberto Cavallaro
@es
Roberto Cavallaro
@nl
Roberto Cavallaro
@sl
prefLabel
Roberto Cavallaro
@ast
Roberto Cavallaro
@en
Roberto Cavallaro
@es
Roberto Cavallaro
@nl
Roberto Cavallaro
@sl
P106
P1153
7003541035
P21
P2798
P31
P496
0000-0002-6877-1456